Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Promising advance in fight against African swine fever
African swine fever virus is a devastating and economically important disease of pigs.
Researchers identify novel proteins to test as vaccine candidates 

Scientists at The Pirbright Institute have made a promising advance in the quest for an African swine fever vaccine.

Writing in the Journal of Virology, researchers describe how they have identified a number of novel immunogenic proteins to test further as vaccine candidates.

“Such an advance is extremely timely due to the continuing spread of ASFV into Eastern Europe,” explained study leader Dr Linda Dixon. “Developing an effective and safe vaccine is therefore of increasing importance to prevent further spread.”

African swine fever virus (ASFV) is a devastating and economically important disease of pigs that is usually fatal. Prevalent in Russia, Sardinia, Sub-Saharan Africa and Eastern Europe, experts have warned that the disease is likely to spread further afield.

There is no vaccine available for ASFV which limits the available options for control. However, researchers at Pirbright have been working on a solution.

Until now, ASF vaccine development work has centred on live attenuated viruses. These are common viruses that have been genetically modified to prevent a full infection, but which can still trigger an immune response.

Although this method is common and effective, scientists say there may be safety issues since the vaccine may cause clinical signs and persist in animals. To overcome this problem, Dr Linda Dixon and her team set out to investigate proteins that induce immune responses that might offer the best protection against infection.

By inserting the gene code for these proteins into Vaccinia - a safe virus that is often used to deliver protective genes to a host - they were able to screen 30 per cent of ASFV genome and ranked 47 genes on their ability to produce proteins that would generate an immune response in pigs.

Researchers say the next step is to test the proteins that had the best immune response and incorporate them into safe vaccines that could eventually be used in the field.

 

Become a member or log in to add this story to your CPD history

Webinar to explore AMR in vet dentistry

News Story 1
 The WSAVA has invited veterinary professionals to a webinar on responsible antibiotic usage in dentistry.

On 19 November 2025, at 1am, Dr J Scott Weese and Dr Brooke Niemiec will share the latest advice for antimicrobial use. They will present research on oral bacterology, and explain how attendees can choose appropriate antibiotics.

The session will cover pre-, intra- and post-operative guidelines, with recommendations for various pathologies.

The webinar is designed to support veterinary professionals to make informed decisions and tackle antimicrobial resistance.

Attendees can register here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com